Anthony Petrone has given his Buy rating due to a combination of factors including Staar Surgical’s robust performance in Japan and EMEA, which counterbalanced challenges in the US and China markets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback